When was Andromedic founded?

Andromedic was founded in 1994.

Where is Andromedic located?

Andromedic is headquartered in Velletri, Italy.

How many employees does Andromedic have?

As of May 31, 2026, the latest employee count at Andromedic is 5.

Is Andromedic a funded company?

Andromedic is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Andromedic rank among its competitors?

Andromedic ranks 40th amongst 67 active competitors, of which 20 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was EmpNia, which secured $9.1M in Nov, 2025.

Who are the top competitors of Andromedic?

Andromedic's top competitors include RefleXion, Alpha Tau Medical and Mevion Medical Systems. Among them, EmpNia secured the most recent funding round in November, 2025.

Andromedic - 2026 Company Profile, Team & Competitors

Andromedic is an unfunded company based in Velletri (Italy), founded in 1994 by Ciro Zaccagnini. It operates as a Provider of oncological hyperthermia therapy. Andromedic has not raised any funding yet. The company has 67 active competitors, including 20 funded and 11 that have exited. Its top competitors include companies like RefleXion, Alpha Tau Medical and Mevion Medical Systems.

Company Details

Andromedic is developing and producing the equipment for oncological hyperthermia therapy for cancer treatment. The product of the company, HY-Deep 600WM is a non-invasive device delivers radio waves to generate thermal energy which kills the cancerous cells.

Website: andromedic.it
Social
Email ID: *****@andromedic.it
Phone Number: +39 **********

Key Metrics

Founded Year

1994

Location

Velletri, Italy

Stage

Unfunded

Ranked

40^th among 67 active competitors

Employee Count

5 as on May 31, 2026

Similar Companies

RefleXion & 79 more

View Andromedic's full profile

Andromedic has not raised any funding rounds yet.

The founders of Andromedic is Ciro Zaccagnini.

Here are the details of Andromedic's key team members:

Ciro Zaccagnini: Founder & CEO of Andromedic.
Contact Info: 1 email address

View details of Andromedic's Founder profiles and Board Members

Andromedic's employee count trend

Andromedic has 5 employees as of May 26. Here is Andromedic's employee count trend over the years:

Uncover Andromedic's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Andromedic include RefleXion, Alpha Tau Medical and Mevion Medical Systems. Here is the list of Top 10 competitors of Andromedic, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	RefleXion 2009, Hayward (United States), Series F	Provider of biology-guided radiotherapy system	$542M	The Rise Fund, PSP Investments & 24 others	70/100
2nd	Alpha Tau Medical 2015, Tel Aviv (Israel), Public	Developer of radiotherapy technique for the treatment of solid cancer tumors	$55M	Shavit Capital, OurCrowd & 15 others	66/100
3rd	Mevion Medical Systems 2004, Littleton (United States), Series F	Proton therapy systems for oncology	$500M	ProQuest Investments, Yuan Ming Capital & 9 others	60/100
4th	Alpheus Medical 2014, Chanhassen (United States), Series B	Developer of Sonodynamic therapy device for brain cancer	$68M	Samsara BioCapital, Orbimed & 7 others	58/100
5th	ZAP-X 2014, San Carlos (United States), Series E	Developer of gyroscopic radiosurgery platform	$160M	Primavera, Foxconn Electronics & 6 others	57/100
6th	ABK Biomedical 2012, Halifax (Canada), Series D	Developer of imageable embolic medical devices targeting benign and malignant hypervascular tumors	$140M	Varian Medical Systems, F-Prime Capital & 8 others	55/100
7th	Cel-Sci 1983, Vienna (United States), Public	Developer of immunotherapy products for the treatment of cancer and infectious diseases	-	Alpha Capital Partners, Midsummer Capital ... & 7 others	53/100
8th	AiRato 2022, Sendai (Japan), Seed	AI-powered radiation therapy platform for cancer treatment	$4.88M	MTG Ventures, GxPartners & 8 others	50/100
9th	Sirtex Medical 1991, Sydney (Australia), Public	Developer of radiation therapy for the treatment of cancer	-	CVC, China Merchants Capital	47/100
10th	EmpNia 2020, Eden Prairie (United States), Series B	Developer of precision imaging and radiation therapy for the treatment of cancer patients	$12.2M	-	46/100
40th	Andromedic 1994, Velletri (Italy), Unfunded	Provider of oncological hyperthermia therapy	-	-	24/100